The reason why the use of oral hypoglycemic agents did not affect insulin dosage significantly in this study may be that the study population were composed of patients with kidney disease who had difficulty in controlling blood glucose and required a large amount of insulin. The gene discussed is INS; the disease is kidney disorder.